Nicolas Maignan is the Chief Operating Officer at Kantify, a pioneering AI-driven drug discovery company. Trained as an engineer at the French National Polytechnic Institute, Nicolas has 8 years of experience in machine learning and leads 16 target identification and drug development pipelines across a wide range of therapeutic areas, including pain, obesity, cancer, rare paediatric diseases, neuromuscular and neurological disorders, and even plant drought resistance. Passionate about applying AI for the benefit of humanity, he specialises in leveraging cutting-edge models to accelerate the discovery of novel therapeutics.
